NCT06958562Not yet recruiting
Relation Between Lymphocyte-to-C-Reactive Protein Ratio and Coronary Artery Disease Complexity
Source: ClinicalTrials.gov · Last updated 6 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Aim(s) of the Research : 1. To assess the relationship between the lymphocyte-to-CRP ratio and CAD complexity as assessed by Syntax score in both emergency (STEMI patients undergoing PPCI) and elective settings (patients undergoing scheduled CA plus PCI). 2. To test the relation between the LCR ratio and short-term major adverse cardiac events (MACE) within 6 months duration in patient undergoing primary PCI.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 12 Apr 2025
- Start date
- 3 Jun 2025
- Primary completion date
- 10 Dec 2025
- Lead sponsor
- Assiut University
- Diseases
- Coronary artery disease
- NCT number
- NCT06958562
What you commit to
- Study type: Observational
- Planned participants: 600
- From 3 Jun 2025 to the primary completion date, 10 Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of myocardial infarction, PCI, or coronary artery bypass grafting (CABG)
- Use of immunosuppressive therapy
Other illness
- Diagnosed autoimmune or chronic inflammatory disorders
- Active infection or malignancy at the time of presentation
Lab values
- Severe renal impairment (eGFR \<30 mL/min/1.73 m²) or hepatic dysfunction
Other
- Diagnosis of acute or chronic leukemia within the past 6 months
Who the study is looking for
- Adults aged 18 to 80 years
- Diagnosed with STEMI undergoing primary PCI within 12 hours of symptom onset
- Patients undergoing elective PCI with documented coronary artery disease
- Provided written informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.